Aug. 7 at 5:53 PM
$PMN Platform strategy
The real jackpot:
PMN267 + PMN442
ProMIS describes three key antibody programs:
PMN310 → Alzheimer's disease /
Amyloid-ß oligomers
=> PMN310 potential
$5-10 bn
* PMN267 → ALS / misfolded TDP-43
=> PMN267 potential
$1-3 bn
* PMN442 → Parkinsons disease, MSA,
=> PMN442 potential
$1-3 bn
and other synucleinopathies
Other Platforms potential
$0,5-2 bn
means in total range from 7.5-18 bn
with a potential Share price of
=>
$405 to
$970
This is not pure fantasy.
$ABBV $TEVA $AMRX
